Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Allarity Therapeutics, Inc. - Common stock
(NQ:
ALLR
)
0.1684
+0.0059 (+3.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,423,468
Open
0.1600
Bid (Size)
0.1690 (30)
Ask (Size)
0.1700 (31)
Prev. Close
0.1625
Today's Range
0.1554 - 0.1717
52wk Range
0.1380 - 38.20
Shares Outstanding
198,742,643
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ALLR Stock Earnings: Allarity Therapeutics Beats EPS for Q2 2024
August 06, 2024
ALLR stock results show that Allarity Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 05, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Performance
YTD
-98.45%
-98.45%
1 Month
-9.71%
-9.71%
3 Month
-73.16%
-73.16%
6 Month
-97.95%
-97.95%
1 Year
-99.48%
-99.48%
More News
Read More
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 30, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 30, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 29, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
July 26, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
July 24, 2024
From
The Schall Law Firm
Via
Business Wire
Rosen Law Firm Encourages Allarity Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – ALLR
July 24, 2024
From
Rosen Law Firm
Via
Business Wire
Why Are Chinese EV Stocks NIO, LI, XPEV Down Today?
July 24, 2024
Via
InvestorPlace
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split
July 24, 2024
Via
InvestorPlace
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 24, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 24, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 24, 2024
Via
InvestorPlace
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares
July 24, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 24, 2024
Via
Benzinga
The Law Offices of Frank R. Cruz Announces Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 23, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Allarity Therapeutics Hit By SEC Notice Related Disclosures Of Once Lead Cancer Program
July 22, 2024
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
July 22, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance
June 27, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
June 25, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered
June 24, 2024
Via
Benzinga
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.